← SynDRA
ZEGOCRACTIN
SynDRA canonical compound SYN0040217 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | ORAI1 | ORAI2 |
|---|
| Mechanism of action | calcium release activated channel modulator |
|---|
All known targets
Mechanisms of action (all sources)
- ORAI1 MODULATOR
- ORAI2 INHIBITOR
- calcium release activated channel modulator
Cross-references
Synonyms
- CM-4620
- CM4620
- CM 4620
- RefChem:195905
- CRAC Inhibitor CM4620
- Orai1 Inhibitor CM4620
- CM128
- CM-128
- Orai Ca2+ Channel Inhibitor CM4620
- Calcium Release-activated Channel Inhibitor CM4620
- Zegocractin [INN]
- Auxora
- MFCD30489478
- Zegocractin (USAN/INN)
- ZEGOCRACTIN [USAN]
- C19H11ClF3N3O3
- UNII-564AW1RR37
- orb1296255
- SCHEMBL18038390
- SCHEMBL29362538
- SCHEMBL29391484
- GTPL10087
- CM 4620 [WHO-DD]
- QQMKTHUGOQDEIL-UHFFFAOYSA-N
- GLXC-23845
- EX-A1898
- NTC24067
- BDBM50575336
- s6834
- AKOS030528045
- compound I [WO2016138472A1]
- SB18686
- AC-35758
- BS-15636
- CM-4620?
- DA-62415
- HY-101942
- CS-0022201
- C73294
Look up ZEGOCRACTIN in the interactive SynDRA portal →